Anaphylaxis Market Report 2026

Anaphylaxis Market Overview

• Anaphylaxis market size has reached to $3.5 billion in 2025 • Expected to grow to $5.14 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: Impact of Rising Food Allergies on the Growth Of The Market • Market Trend: Product Innovations Driving Advancements In The Treatment • North America was the largest region in 2025.

What Is Covered Under Anaphylaxis Market?

Anaphylaxis is a severe, life-threatening allergic reaction that occurs rapidly, often resulting in difficulty breathing, swelling, and a drop in blood pressure, requiring immediate medical intervention. Management of anaphylaxis involves prompt administration of epinephrine, followed by monitoring in a healthcare setting to stabilize the patient and prevent further complications. The main drug classes in anaphylaxis are epinephrine, steroids, antihistamines, beta-antagonists, and others. Epinephrine is a life-saving medication used to rapidly reverse severe allergic reactions, such as anaphylaxis, by constricting blood vessels, relaxing airway muscles, and increasing heart rate. These are administered by routes including parenteral, oral, and others for the applications such as food allergy, pollen allergy, dust mite’s allergy, and others.

What Is The Anaphylaxis Market Growth Forecast?

The anaphylaxis market size is expected to see strong growth in the next few years. It will grow to $5.14 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing access to emergency allergy care, rising demand for portable treatment solutions, expansion of allergy specialty services, growing focus on patient education programs, increasing investment in allergy management infrastructure. Major trends in the forecast period include increasing availability of epinephrine auto-injectors, rising awareness of severe allergic reactions, growing emphasis on emergency preparedness, expansion of allergy diagnosis and monitoring, enhanced focus on rapid response protocols.

Global Anaphylaxis Market Segmentation

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Other Drug Class 2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration 3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications Subsegments: 1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials 2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids 3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists 4) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

What Is The Driver Of The Anaphylaxis Market?

The rising prevalence of food allergies is expected to propel the growth of the anaphylaxis market going forward. Food allergies are immune system reactions triggered by certain foods, causing symptoms that range from mild to severe, including life-threatening anaphylaxis. The rising prevalence of food allergies are due to factors such as changing dietary habits, environmental influences, and improved awareness and diagnosis. Anaphylaxis treatment provides critical, life-saving intervention for food allergy patients by rapidly reversing severe allergic reactions, reducing symptoms such as swelling, difficulty breathing, and drop in blood pressure, ensuring immediate stabilization and preventing potentially fatal outcomes, while empowering patients with the tools for timely action in future allergic incidents. For instance, in September 2024, according to the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, around 220 million people globally are affected by food allergies. A single food product can include multiple allergens, and individuals may be allergic to more than one type of food. Additionally, in May 2024, according to the Patterns and Prevalence of Adult Food Allergy (PAFA) report published by the Food Standards Agency (FSA), a UK-based non-ministerial department, over 30% of adults reported food-related adverse reactions, and clinical assessments confirmed food allergies in approximately 6% of UK adults, equating to around 2.4 million people. Therefore, the rising prevalence of food allergies is driving the growth of the anaphylaxis industry.

Key Players In The Global Anaphylaxis Market

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Global Anaphylaxis Market Trends and Insights

Major companies operating in the anaphylaxis market are focusing on developing advanced epinephrine nasal spray, which enable faster, more efficient drug delivery during emergencies. Epinephrine nasal spray is a medical device that delivers epinephrine (adrenaline) through the nasal passages as a treatment for severe allergic reactions, including anaphylaxis. For instance, in August 2024, ARS Pharmaceuticals, a US-based biotechnology company, announced Neffy (epinephrine nasal spray) approved by the Food and Drug Administration, a US-based government agency, marking it as the first and only needle-free treatment for type I allergic reactions, including anaphylaxis. This innovative nasal spray provides a non-invasive alternative to traditional epinephrine autoinjectors, offering a potentially more accessible option for emergency treatment. Neffy aims to improve patient compliance by eliminating the need for needles while delivering rapid, life-saving epinephrine during severe allergic reactions.

What Are Latest Mergers And Acquisitions In The Anaphylaxis Market?

In October 2023, Nestlé Health Science SA, a Switzerland-based nutritional science company that offers anaphylaxis, announced a partnership with Anaphylaxis UK, to supporting individuals with severe allergies. This collaboration aims to raise awareness about the serious consequences of anaphylaxis and empower people to manage allergies safely through education and resources. Anaphylaxis UK is a UK-based severe allergies charity.

Regional Outlook

North America was the largest region in the anaphylaxis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Anaphylaxis Market?

The anaphylaxis market consists of syringes and vials, intravenous (IV) epinephrine, diagnostic kits, and monitoring devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anaphylaxis Market Report 2026?

The anaphylaxis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anaphylaxis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.